Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?

Voskarides K, Papagregoriou G, Hadjipanagi D, Petrou I, Savva I, Elia A, Athanasiou Y, Pastelli A, Kkolou M, Hadjigavriel M, Stavrou C, Pierides A, Deltas C.

BMC Nephrol. 2018 May 16;19(1):114. doi: 10.1186/s12882-018-0906-5.

2.

Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.

Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, Stylianou K, Ioannou P, Xydakis D, Tzanakis I, Papadaki A, Kallivretakis N, Nikolakakis N, Perysinaki G, Gale DP, Diamantopoulos A, Goudas P, Goumenos D, Soloukides A, Boletis I, Melexopoulou C, Georgaki E, Frysira E, Komianou F, Grekas D, Paliouras C, Alivanis P, Vergoulas G, Pierides A, Daphnis E, Deltas C.

Clin Genet. 2017 Nov;92(5):517-527. doi: 10.1111/cge.13077. Epub 2017 Sep 25.

PMID:
28632965
3.

A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population.

Voskarides K, Stefanou C, Pieri M, Demosthenous P, Felekkis K, Arsali M, Athanasiou Y, Xydakis D, Stylianou K, Daphnis E, Goulielmos G, Loizou P, Savige J, Höhne M, Völker LA, Benzing T, Maxwell PH, Gale DP, Gorski M, Böger C, Kollerits B, Kronenberg F, Paulweber B, Zavros M, Pierides A, Deltas C.

PLoS One. 2017 Mar 23;12(3):e0174274. doi: 10.1371/journal.pone.0174274. eCollection 2017.

4.

RAAS inhibition and the course of Alport syndrome.

Savva I, Pierides A, Deltas C.

Pharmacol Res. 2016 May;107:205-210. doi: 10.1016/j.phrs.2016.03.017. Epub 2016 Mar 16. Review.

PMID:
26995302
5.

Molecular and Clinical Investigation of Cystinuria in the Greek-Cypriot Population.

Athanasiou Y, Voskarides K, Chatzikyriakidou A, Ignatiou A, Demosthenous P, Elia A, Zavros M, Georgiou I, Pierides A, Deltas C.

Genet Test Mol Biomarkers. 2015 Nov;19(11):641-5. doi: 10.1089/gtmb.2015.0144. Epub 2015 Nov 5.

PMID:
26540609
6.

Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.

Deltas C, Savva I, Voskarides K, Papazachariou L, Pierides A.

Nephron. 2015;130(4):271-80. doi: 10.1159/000435789. Epub 2015 Jul 17. Review.

PMID:
26201269
7.

The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression.

Amaya R, Pierides A, Tarbell JM.

PLoS One. 2015 Jul 6;10(7):e0129952. doi: 10.1371/journal.pone.0129952. eCollection 2015.

8.

Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure.

Stefanou C, Pieri M, Savva I, Georgiou G, Pierides A, Voskarides K, Deltas C.

Nephron. 2015;130(3):200-12. doi: 10.1159/000432406. Epub 2015 Jun 26.

PMID:
26138234
9.

COL4A3/COL4A4 heterozygous mutations with TBMN presenting as focal segmental glomerulosclerosis.

Deltas C, Pierides A.

Kidney Int. 2015 Apr;87(4):859. doi: 10.1038/ki.2015.38. No abstract available.

PMID:
25826548
10.

Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.

Papazachariou L, Demosthenous P, Pieri M, Papagregoriou G, Savva I, Stavrou C, Zavros M, Athanasiou Y, Ioannou K, Patsias C, Panagides A, Potamitis C, Demetriou K, Prikis M, Hadjigavriel M, Kkolou M, Loukaidou P, Pastelli A, Michael A, Lazarou A, Arsali M, Damianou L, Goutziamani I, Soloukides A, Yioukas L, Elia A, Zouvani I, Polycarpou P, Pierides A, Voskarides K, Deltas C.

PLoS One. 2014 Dec 16;9(12):e115015. doi: 10.1371/journal.pone.0115015. eCollection 2014.

11.

Familial Mediterranean fever associated with MEFV mutations in a large cohort of Cypriot patients.

Neocleous V, Costi C, Kyriakou C, Kyriakides TC, Shammas C, Skordis N, Toumba M, Kyriakou S, Koliou M, Kousparou M, Onoufriou M, Hadjipanayis A, Iasonides M, Atamyan VN, Pierides A, Christophidou-Anastasiadou V, Tanteles GA, Phylactou LA.

Ann Hum Genet. 2015 Jan;79(1):20-7. doi: 10.1111/ahg.12087. Epub 2014 Nov 13.

12.
13.

High glucose attenuates shear-induced changes in endothelial hydraulic conductivity by degrading the glycocalyx.

Lopez-Quintero SV, Cancel LM, Pierides A, Antonetti D, Spray DC, Tarbell JM.

PLoS One. 2013 Nov 18;8(11):e78954. doi: 10.1371/journal.pone.0078954. eCollection 2013.

14.

Molecular genetics of familial hematuric diseases.

Deltas C, Pierides A, Voskarides K.

Nephrol Dial Transplant. 2013 Dec;28(12):2946-60. doi: 10.1093/ndt/gft253. Epub 2013 Sep 17. Review.

PMID:
24046192
15.

Epistatic role of the MYH9/APOL1 region on familial hematuria genes.

Voskarides K, Demosthenous P, Papazachariou L, Arsali M, Athanasiou Y, Zavros M, Stylianou K, Xydakis D, Daphnis E, Gale DP, Maxwell PH, Elia A, Pattaro C, Pierides A, Deltas C.

PLoS One. 2013;8(3):e57925. doi: 10.1371/journal.pone.0057925. Epub 2013 Mar 14.

16.

C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.

Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.

Adv Exp Med Biol. 2013;735:189-96. Review.

PMID:
23402027
17.

On 'Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations'.

Voskarides K, Pierides A, Deltas C.

Kidney Int. 2013 Feb;83(2):331. doi: 10.1038/ki.2012.376. No abstract available.

18.

A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy.

Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y, Pierides A, Gretz N, Felekkis KN, Deltas C.

PLoS One. 2012;7(2):e31021. doi: 10.1371/journal.pone.0031021. Epub 2012 Feb 2.

19.

Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuria.

Voskarides K, Arsali M, Athanasiou Y, Elia A, Pierides A, Deltas C.

Pediatr Nephrol. 2012 Apr;27(4):675-9. doi: 10.1007/s00467-011-2084-6. Epub 2012 Jan 8.

PMID:
22228437
20.

The role of molecular genetics in diagnosing familial hematuria(s).

Deltas C, Pierides A, Voskarides K.

Pediatr Nephrol. 2012 Aug;27(8):1221-31. doi: 10.1007/s00467-011-1935-5. Epub 2011 Jun 19. Review.

21.

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.

22.

X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5.

Demosthenous P, Voskarides K, Stylianou K, Hadjigavriel M, Arsali M, Patsias C, Georgaki E, Zirogiannis P, Stavrou C, Daphnis E, Pierides A, Deltas C; Hellenic Nephrogenetics Research Consortium.

Clin Genet. 2012 Mar;81(3):240-8. doi: 10.1111/j.1399-0004.2011.01647.x. Epub 2011 Mar 13.

PMID:
21332469
23.

Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant.

Vernon KA, Gale DP, de Jorge EG, McLean AG, Galliford J, Pierides A, Maxwell PH, Taube D, Pickering MC, Cook HT.

Am J Transplant. 2011 Jan;11(1):152-5. doi: 10.1111/j.1600-6143.2010.03333.x. Epub 2010 Nov 29.

24.

Founder mutations in the ATP6V1B1 gene explain most Cypriot cases of distal renal tubular acidosis: first prenatal diagnosis.

Elia A, Voskarides K, Demosthenous P, Michalopoulou A, Malliarou MA, Georgaki E, Athanasiou Y, Patsias C, Pierides A, Deltas C.

Nephron Clin Pract. 2011;117(3):c206-12. doi: 10.1159/000320192. Epub 2010 Aug 30.

PMID:
20805693
25.

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.

Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.

Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

26.

Genetic variation of DKK3 may modify renal disease severity in ADPKD.

Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, Zerres K, Bogdanova N, Coto E, Deltas C, Pierides A, Demetriou K, Devuyst O, Gitomer B, Laakso M, Lumiaho A, Lamnissou K, Magistroni R, Parfrey P, Breuning M, Peters DJ, Torra R, Winearls CG, Torres VE, Harris PC, Paterson AD, Pei Y.

J Am Soc Nephrol. 2010 Sep;21(9):1510-20. doi: 10.1681/ASN.2010030237. Epub 2010 Jul 8.

27.

Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis V, Patsias C, Zouvani I, Elia A, Kyriacou K, Deltas C.

Nephrol Dial Transplant. 2009 Sep;24(9):2721-9. doi: 10.1093/ndt/gfp158. Epub 2009 Apr 8.

PMID:
19357112
28.

Incidence of thin basement membrane nephropathy in 990 consecutive renal biopsies examined with electron microscopy.

Zouvani I, Aristodemou S, Hadjisavvas A, Michael T, Vassiliou M, Patsias C, Pierides A, Ioannou K, Kyriacou K.

Ultrastruct Pathol. 2008 Nov-Dec;32(6):221-6. doi: 10.1080/01913120802529859.

PMID:
19117263
29.

COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?

Voskarides K, Pierides A, Deltas C.

Connect Tissue Res. 2008;49(3):283-8. doi: 10.1080/03008200802148280.

PMID:
18661361
30.

COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century.

Voskarides K, Patsias C, Pierides A, Deltas C.

Genet Test. 2008 Jun;12(2):273-8. doi: 10.1089/gte.2007.0110.

PMID:
18439107
31.

NPHS2 screening with SURVEYOR in Hellenic children with steroid-resistant nephrotic syndrome.

Voskarides K, Makariou C, Papagregoriou G, Stergiou N, Printza N, Alexopoulos E, Elia A, Papachristou F, Pierides A, Georgaki E, Deltas C.

Pediatr Nephrol. 2008 Aug;23(8):1373-5. doi: 10.1007/s00467-008-0804-3. Epub 2008 Apr 5. No abstract available.

PMID:
18392643
32.

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy.

Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, Ioannou K, Athanasiou Y, Patsias C, Alexopoulos E, Pierides A, Kyriacou K, Deltas C.

J Am Soc Nephrol. 2007 Nov;18(11):3004-16. Epub 2007 Oct 17.

34.

The MTHFR 677TT and 677CT/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure.

Koupepidou P, Deltas C, Christofides TC, Athanasiou Y, Zouvani I, Pierides A.

Int Angiol. 2005 Sep;24(3):287-94.

PMID:
16158041
35.

Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.

Lamnissou K, Zirogiannis P, Trygonis S, Demetriou K, Pierides A, Koptides M, Deltas CC.

Genet Test. 2004 Fall;8(3):319-24.

PMID:
15727257
36.

Modification of the enzyme mismatch cleavage method using T7 endonuclease I and silver staining.

Mean RJ, Pierides A, Deltas CC, Koptides M.

Biotechniques. 2004 May;36(5):758-60. No abstract available.

37.

A simplified method for measuring the thickness of glomerular basement membranes.

Marquez B, Zouvani I, Karagrigoriou A, Anastasiades E, Pierides A, Kyriacou K.

Ultrastruct Pathol. 2003 Nov-Dec;27(6):409-16.

PMID:
14660279
38.

Outcome of kidney transplantation in autosomal dominant medullary cystic kidney disease type 1.

Stavrou C, Deltas CC, Christophides TC, Pierides A.

Nephrol Dial Transplant. 2003 Oct;18(10):2165-9.

PMID:
13679497
39.

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y.

J Am Soc Nephrol. 2003 May;14(5):1164-74.

40.

Autosomal-dominant medullary cystic kidney disease type 1: clinical and molecular findings in six large Cypriot families.

Stavrou C, Koptides M, Tombazos C, Psara E, Patsias C, Zouvani I, Kyriacou K, Hildebrandt F, Christofides T, Pierides A, Deltas CC.

Kidney Int. 2002 Oct;62(4):1385-94. Erratum in: Kidney Int 2002 Nov;62(5):1920..

41.

Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus.

Deltas CC, Mean R, Rossou E, Costi C, Koupepidou P, Hadjiyanni I, Hadjiroussos V, Petrou P, Pierides A, Lamnisou K, Koptides M.

Genet Test. 2002 Spring;6(1):15-21.

PMID:
12180071
42.

A family with the branchio-oto-renal syndrome: clinical and genetic correlations.

Pierides AM, Athanasiou Y, Demetriou K, Koptides M, Deltas CC.

Nephrol Dial Transplant. 2002 Jun;17(6):1014-8.

PMID:
12032190
43.

Novel NPR1 polymorphic variants and its exclusion as a candidate gene for medullary cystic kidney disease (ADMCKD) type 1.

Koptides M, Mean R, Stavrou C, Pierides A, Demetriou K, Nakayama T, Hildebrandt F, Fuchshuber A, Deltas CC.

Mol Cell Probes. 2001 Dec;15(6):357-61.

PMID:
11851379
44.

Novel PKD1 deletions and missense variants in a cohort of Hellenic polycystic kidney disease families.

Bouba I, Koptides M, Mean R, Costi CE, Demetriou K, Georgiou I, Pierides A, Siamopoulos K, Deltas CC.

Eur J Hum Genet. 2001 Sep;9(9):677-84.

45.
46.

Screening of the PKD1 duplicated region reveals multiple single nucleotide polymorphisms and a de novo mutation in Hellenic polycystic kidney disease families.

Koptides M, Mean R, Demetriou K, Constantinides R, Pierides A, Harris PC, Deltas CC.

Hum Mutat. 2000 Aug;16(2):176.

PMID:
10923040
47.

Geographical clustering of low density lipoprotein receptor gene mutations (C292X; Q363X; D365E & C660X) in Cyprus.

Xenophontos SL, Pierides A, Demetriou K, Avraamides P, Manoli P, Ayrton N, Skordis N, Anastasiadou V, Miltiadous G, Cariolou MA.

Hum Mutat. 2000 Apr;15(4):380.

PMID:
10737984
48.

Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease.

Koptides M, Mean R, Demetriou K, Pierides A, Deltas CC.

Hum Mol Genet. 2000 Feb 12;9(3):447-52.

PMID:
10655555
49.

Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations.

Demetriou K, Tziakouri C, Anninou K, Eleftheriou A, Koptides M, Nicolaou A, Deltas CC, Pierides A.

Nephrol Dial Transplant. 2000 Feb;15(2):205-11.

PMID:
10648666
50.

Thin glomerular basement membranes in patients with hematuria and minimal change disease.

Marquez B, Stavrou F, Zouvani I, Anastasiades E, Patsias C, Pierides A, Kyriacou K.

Ultrastruct Pathol. 1999 May-Jun;23(3):149-56.

PMID:
10445281

Supplemental Content

Loading ...
Support Center